TransCode Therapeutics, Inc.

8-K Modified rights of security holders; Amended charter or bylaws Aug 3, 2026 8-K Shareholder vote results Jul 20, 2026 8-K Modified rights of security holders; Amended charter or bylaws Jul 17, 2026 8-K Other events Jul 2, 2026 8-K Regulation FD disclosure Jun 18, 2026 8-K Other events Jun 3, 2026 8-K Item 5.08 Jun 1, 2026 8-K/A Delisting notice or listing-rule failure May 26, 2026 8-K Delisting notice or listing-rule failure May 22, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 30, 2026 10-K Fiscal year ended 2025-12-31 Apr 15, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Regulation FD disclosure Apr 7, 2026 8-K Unregistered sale of equity; Modified rights of security holders; Amended charter or bylaws; Regulation FD disclosure; Other events Mar 3, 2026 8-K Regulation FD disclosure Feb 23, 2026 8-K Regulation FD disclosure Feb 5, 2026 8-K Regulation FD disclosure Jan 6, 2026 8-K/A Other events Dec 23, 2025 8-K Director or officer change; Regulation FD disclosure Dec 22, 2025 8-K Regulation FD disclosure Dec 11, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Modified rights of security holders; Amended charter or bylaws Oct 27, 2025 8-K/A Entered a material agreement Oct 17, 2025 8-K Other events Oct 14, 2025 8-K/A Entered a material agreement Oct 8, 2025 8-K Entered a material agreement; Completed an acquisition or disposition; Unregistered sale of equity; Modified rights of security holders; Director or officer change; Amended charter or bylaws; Regulation FD disclosure Oct 8, 2025 8-K Entered a material agreement Oct 3, 2025 8-K Shareholder vote results Sep 2, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Item 5.08 Jun 13, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Delisting notice or listing-rule failure May 7, 2025 8-K Modified rights of security holders; Amended charter or bylaws; Regulation FD disclosure May 5, 2025 8-K Shareholder vote results; Regulation FD disclosure May 2, 2025 10-K/A Fiscal year ended 2024-12-31 Apr 30, 2025 8-K Shareholder vote results; Other events Apr 21, 2025 10-K Fiscal year ended 2024-12-31 Apr 15, 2025 8-K Entered a material agreement; Other events Mar 25, 2025 8-K Shareholder vote results; Other events Feb 25, 2025 8-K Shareholder vote results; Other events Feb 4, 2025